Form 8-K - Current report:
SEC Accession No. 0001023024-08-000004
Filing Date
2008-03-17
Accepted
2008-03-17 16:35:59
Documents
3
Period of Report
2008-03-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8K FOR FIANCIAL RELEASE 3-17-08 form8kyearended123107.htm 8-K 25522
2 NEWS RELEASE exhibit99w1.htm EX-99.1 24417
3 LOGO bpaxlogo1.jpg GRAPHIC 8292
  Complete submission text file 0001023024-08-000004.txt   63146
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 08693340
SIC: 2836 Biological Products, (No Diagnostic Substances)